Clik here to view.
New players in sequencing debut at AGBT
The main theme of this year’s Advances in Genome Biology and Technology meeting should come as no surprise to regular readers: sequencing. Generating as many bases of DNA sequence as quickly, cheaply...
View ArticleClik here to view.
State of sequencing technology in 2010
Dan Koboldt has a very nice recap of the various sequencing technologies presented at last week’s Advances in Genome Biology and Technology meeting. I totally agree with his central point: Something...
View ArticleClik here to view.
Celebrity genomics without the Y chromosome: Glenn Close has her genome...
Zoe McDougall from Oxford Nanopore points me to a press release from Illumina announcing a new era of celebrity genomics: Illumina, Inc. (NASDAQ:ILMN) today announced that it has sequenced the DNA of...
View ArticleClik here to view.
Estimating the number of sequencers in the wild using a WWII formula
Nick Loman (of the University of Birmingham, and the Pathogens: Genes and Genomes blog) has a post updating us on his survey of second-generation sequencing machines around the world. Loman’s results...
View ArticleSequencing your genome just got cheaper
Jay Flatley, CEO of sequencing giant Illumina, announced at the Consumer Genetics Conference today that the company had reduced the price of its retail whole-genome sequencing service. At $19,500 this...
View ArticleWhy sequencing matters for personal genomics
The first ever post on the new group blog I announced yesterday, Genomes Unzipped, is now live: it’s Luke Jostins of Genetic Inference talking about the importance of sequencing for the future of...
View ArticleBattle for the genome continues: Pacific Biosciences goes public
The long-awaited public stock offer from third-generation sequencing technology company Pacific Biosciences has finally arrived (here’s the SEC filing, and coverage from Matthew Herper and GenomeWeb)....
View ArticleIon Torrent bought by Life Technologies
More huge news in the sequencing industry, following on from the public share offer from Pacific Biosciences - relative newcomer to the field, Ion Torrent, has just been bought by Life Technologies for...
View ArticleWhy you CAN have your $1000 genome – so long as you learn what to do with it
As part of his Gene Week celebration over at Forbes, Matthew Herper has a provocative post titled “Why you can’t have your $1000 genome“. In this post I’ll explain why, while Herper’s pessimism is...
View ArticleOne more step towards the end of recessive diseases
In the last century infant mortality has declined precipitously in the Western world, thanks in large part to the development of antibiotics and vaccination. Yet as the suffering and death from...
View Article
